Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACSM1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | EAF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
mRNA | HDHD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | HPF1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | MAPK3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | EHD1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | PRDX2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | SYT6 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
mRNA | MOB1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | MAN2A2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |